Mirum Pharmaceuticals (MIRM) Work In Process (2021 - 2026)
Mirum Pharmaceuticals (MIRM) posted quarterly Work In Process of $19.5 million for Q1 2026, up 23.21% year-over-year from $15.8 million in Q1 2025, and up 5.49% quarter-over-quarter from $18.5 million in Q4 2025.
Mirum Pharmaceuticals (MIRM) Work In Process (2021 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Work In Process history runs 6 years deep, the most recent figure standing at $19.5 million for Q1 2026.
- In Q1 2026, Work In Process rose 23.21% year-over-year to $19.5 million; the TTM figure through Mar 2026 stood at $19.5 million (up 23.21% YoY), while the FY2025 annual figure was $18.5 million, up 14.82% from the prior year.
- Work In Process for Q1 2026 stood at $19.5 million, up from $18.5 million in the prior quarter.
- The five-year high for Work In Process was $19.5 million in Q1 2026, with the low at $553000.0 in Q1 2022.
- The 5-year median for Work In Process is $10.8 million (2024), against an average of $11.3 million.
- The sharpest annual moves came in 2023 and 2025: Work In Process soared 1072.51% in 2023, then advanced 14.82% in 2025.
- Mirum Pharmaceuticals' Work In Process stood at $5.4 million in 2022, then soared by 84.51% to $9.9 million in 2023, then soared by 62.96% to $16.1 million in 2024, then advanced by 14.82% to $18.5 million in 2025, then climbed by 5.49% to $19.5 million in 2026.
- Business Quant data shows MIRM's Work In Process at $19.5 million in Q1 2026, $18.5 million in Q4 2025, and $18.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Mirum Pharmaceuticals | 6.52 Bn | 6.08 Bn | 145.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.14 Mn |
| Mar 31, 2026 | 19.49 Mn |
| Dec 31, 2025 | 18.47 Mn |
| Sep 30, 2025 | 18.31 Mn |
| Jun 30, 2025 | 16.31 Mn |
| Mar 31, 2025 | 15.82 Mn |
| Dec 31, 2024 | 16.09 Mn |
| Sep 30, 2024 | 14.26 Mn |
| Jun 30, 2024 | 11.59 Mn |
| Mar 31, 2024 | 10.85 Mn |
| Dec 31, 2023 | 9.87 Mn |
| Sep 30, 2023 | 10.53 Mn |
| Jun 30, 2023 | 6.97 Mn |
| Mar 31, 2023 | 6.48 Mn |
| Dec 31, 2022 | 5.35 Mn |
| Sep 30, 2022 | 6.76 Mn |
| Jun 30, 2022 | 4.29 Mn |
| Mar 31, 2022 | 553,000.00 |
| Dec 31, 2021 | 570,000.00 |